Aredia

Common Brands Aredia​
Drug Class
Bisphosphonates
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Availability
Prescription only
Kristianne Hannemann, PharmD
Kristianne Hannemann, PharmD
Read More
Medically reviewed by Kristianne Hannemann, PharmD last update on 20/12/2023

Overview

Aredia is a bisphosphonate drug which contains the active ingredient pamidronate disodium. It is mainly prescribed for the management of bone metabolism-related diseases. This drug is frequently used in the treatment of high blood calcium levels that arise due to cancer, certain kinds of cancer-induced bone pains associated with metastasis, and bone disease like Paget’s disease. Pamidronate works by inhibiting bone resorption, that is, the process by which bone is broken down and its minerals are released into the bloodstream. It stabilizes the bone structure and reduces the risk of fractures in patients with weakened bones due to various conditions, including cancer and osteoporosis.

 

Aredia is typically administered intravenously (IV) in a clinical setting, such as a hospital or outpatient infusion center. The dosage and frequency of administration depend on the patient’s condition and response to treatment.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy